Photo: News 18
AstraZeneca's Updated US Trials Reveal 76% Efficacy Against COVID-19
Oxford-AstraZeneca COVID-19 vaccine has shown 76% efficacy in its recent trials, claimed the pharmaceutical giant on March 25. The trial data came a week after the US health officials accused AstraZeneca of using "outdated information". Approved in over 70 countries, the vaccine was recently tested on 32,449 people in the US, Peru, and Chile, claiming 85% efficacy in people above 65. Notably, the other two US-made vaccines, Pfizer/BioNTech… read-more
Tags: Covid Vaccine, Vaccination, Oxford-AstraZeneca, Pfizer
Courtesy: Hindustan Times
Photo: Punekar News
Covishield To Cost Rs 440 At Govt Stores: SII CEO Adar Poonwalla
Serum Institute of India (SII) CEO Adar Poonawalla on December 31 stated that the Covishield vaccine would be sold at Rs 440 ($6) in the government stores. However, the prices at private markets have been estimated at around Rs 700-800. The SII got approval for Emergency Use Authorization (EUA) of Oxford-AstraZeneca vaccine in the UK on December 30. Reportedly, 40 million doses of Covishield vaccine have already been manufactured.
Tags: SII, COVISHIELD, Oxford-AstraZeneca, Adar Poonawalla
Courtesy: India.com
